Cell Therapeutics, Inc. (Nasdaq: CTICD) reports that it has identified a potential acquisition opportunity that is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE